Raising capital start-up biomarkers Sepsi – EUR 5 million

We are raising capital for a project of ultra-rapid testing of biomarkers to underpin therapeutic decisions for sepsi.

Sepsis is a life-threatening organ dysfunction caused by dysregulated host response to infection (mainly bacteria or fungi). Septic shock – a subset of sepsis – is associated with circulatory and cellular/metabolic dysfunction and associated with a higher risk of mortality.

We are looking for EUR 5 million equity.

Be Sociable, Share!